Biao He
Directeur/Bestuurslid bij BioEclipse Therapeutics, Inc.
Profiel
Biao He is currently a Director at BioEclipse Therapeutics, Inc. He was previously a Venture Partner at Tsinghua Silicon Valley Capital.
Actieve functies van Biao He
Bedrijven | Functie | Begin |
---|---|---|
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Biao He
Bedrijven | Functie | Einde |
---|---|---|
Tsinghua Silicon Valley Capital
Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Private Equity Investor | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Tsinghua Silicon Valley Capital
Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Finance |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |